Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Venus Remedies Limited ( (IN:VENUSREM) ) is now available.
Venus Remedies Limited has notified the stock exchange that it has published its unaudited financial results for the period ended 31 December 2025 in newspapers, in compliance with disclosure requirements under Regulation 30 of the Listing Obligations and Disclosure Requirements (LODR). The move underscores the company’s adherence to statutory transparency and reporting norms, providing stakeholders with timely access to its quarterly financial performance and reinforcing its governance and compliance standards in the pharmaceutical sector.
More about Venus Remedies Limited
Venus Remedies Limited is an India-based pharmaceutical company with corporate operations in Panchkula, Haryana, and a registered office in Chandigarh. The company operates multiple manufacturing units in India and a subsidiary, Venus Pharma GmbH, in Germany, reflecting its presence in both domestic and international pharmaceutical markets.
Average Trading Volume: 7,987
Technical Sentiment Signal: Buy
Current Market Cap: 10.94B INR
Find detailed analytics on VENUSREM stock on TipRanks’ Stock Analysis page.